Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05329688
Other study ID # IRB110-196-A
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date December 30, 2025

Study information

Verified date April 2022
Source Taipei Medical University WanFang Hospital
Contact Szu-Yuan Wu
Phone +886910603955
Email szuyuanwu5399@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using randomized control study, explore the effect of novel nutrition education program on the nutrition status and life quality of cancer patients receiving radiotherapy


Description:

Weight loss is common among cancer patients, and can be attributed to many causes, including mucositis, inability to ingest or absorb adequate calories because of a problem with the alimentary tract, loss of appetite, and metabolic aberrations. Unintentional weight loss may be associated with decreased quality of life (QOL) and a poorer prognosis. Furthermore, for patients who are already in a catabolic state, the increased metabolic demands associated with anticancer treatment (particularly surgery) further worsen the problem. The novel nutrition program might improve the nutrition status and QOL in cancer patients receiving radiotherapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 30, 2025
Est. primary completion date December 30, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Patients are diagnosed with cancer and receive radiotherapy, especially in head and neck cancer, lung cancer, or esophageal cancer. 2. Patients need nutrition support treatment 3. Informed consent Exclusion Criteria: 1. Critical patients or life expectancy < 12 weeks 2. Patients with severe hepatic cirrhosis, Chronic Obstructive Pulmonary Disease, chronic renal failure, intestinal obstruction, stroke. 3. Unconscious or psychiatric patients 4. Patients with communication problems

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
novel nutrition program
Give nutrition health education every two weeks and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.

Locations

Country Name City State
Taiwan Szu-Yuan Wu Taipei Please Select

Sponsors (2)

Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital Asia University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary risk of malnutrition Nutrition Risk Screening 2002 is used to assess the risk of malnutrition. Week 0, 12
Primary BMI Body mass index is a measure of body fat based on height and weight that applies to adult men and women. It equals to weight divided by height square. Week 0, 12
Primary albumin level of serum albumin Week 0, 12
Primary Quality of Life (QOL) The QOL was measured by the European Organization for Research and Treatment quality of life version 3 questionnaire (EORTC QLQ-C30) simplified Chinese version. It contains five functional scales (physical, role, cognitive, emotional, and social), three symptoms scales (fatigue, pain, and nausea and vomiting), a global health scale, a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, appetite loss, insomnia, constipation, and diarrhea) and financial impact of the disease. For most items, four response categories from 1 (not at all) to 4 (very much) are employed; two items (overall health, overall quality of life) have response categories ranging from 1 to 7. A high scale score represents a higher response level. Thus a high score for a functional scale, the global health status or overall QOL represents a high or healthy status or a high QOL; however, a high score for the symptom scales represents a high level of symptom. Week 0, 12
Secondary physical function status Using Eastern Cooperative Oncology Group to assess the physical function. Week 0, 12
Secondary Knowledge-Attitude-Practice Knowledge Scale composes of 10 questions and 10 scores for each question. Attitude and Practice Scale have 5 questions. Each question is rated as A?B?C. A represents 20 score and B is 10 score. Week 0, 12
See also
  Status Clinical Trial Phase
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Recruiting NCT05543239 - Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain N/A
Terminated NCT04535908 - Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older. N/A
Recruiting NCT04115267 - Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
Recruiting NCT05820633 - Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer. N/A
Completed NCT05880446 - PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) N/A
Recruiting NCT05724004 - Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB) N/A
Recruiting NCT04612907 - Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer N/A
Recruiting NCT05762900 - Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients Phase 2
Recruiting NCT03613506 - The Role and Intervention of TGF-β in Abdominal Radiation Injury Phase 2
Completed NCT06353724 - Comparison Between the Effect of Using Conventional and Digital Oral Positional Radiation Stent N/A
Not yet recruiting NCT05548504 - Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC Phase 2
Recruiting NCT05224297 - Patient Experience Data in Radiation Oncology
Recruiting NCT05776147 - Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
Completed NCT04842409 - Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery
Recruiting NCT03742687 - Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC N/A
Not yet recruiting NCT05614700 - Prostate Reirradiation Toxicity Outcomes Feasibility Study N/A
Completed NCT04027543 - Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
Recruiting NCT05354596 - A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY). N/A
Recruiting NCT03378856 - Evaluation of Technological Innovation in Radiotherapy